• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study supports “catch up” HPV test in older women

Bioengineer by Bioengineer
July 6, 2023
in Health
Reading Time: 3 mins read
0
Study supports “catch up” HPV test in older women
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a “catch up” HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as compared to women not offered screening. That is the conclusion of a new study publishing July 6th in the open access journal PLOS Medicine by Mette Tranberg, University Research Clinic for Cancer Screening, Randers Regional Hospital, Denmark, and colleagues.

Study supports"catch up" HPV test in older women

Credit: Helle Brandstrup Larsen (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a “catch up” HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as compared to women not offered screening. That is the conclusion of a new study publishing July 6th in the open access journal PLOS Medicine by Mette Tranberg, University Research Clinic for Cancer Screening, Randers Regional Hospital, Denmark, and colleagues.

High-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical cancer screening test in most countries, but many women over 65 years have never had an HPV test. Controversy remains on whether and how these women should be offered a catch-up HPV test to prevent cancer at older ages.

Denmark has a free-of-charge cervical cancer screening program aimed at women up to age 64. The new study included all 65- to 69-year-old women in Denmark who had no record of cervical cancer screening in the preceding 5.5 years and no record of an HPV test at ages 60 to 64. 11,192 eligible women residing in one region were invited to participate in HPV-based cervical cancer screening, by either booking an appointment (at the general practitioner to have a cervical cytology sample collected) or ordering a vaginal self-sampling kit. 33,387 eligible women in the four remaining regions of Denmark were assigned to a control group where they received no screening invitation but had the opportunity to have an opportunistic cervical cytology sample collected for whatever reason. Among all participants, rates of diagnosed cervical intraepithelial neoplasia (CIN) grade two or worse (CIN2+) were tracked for at least 13 months.

Among women in the intervention group, 6,965 (62.2%) were screened within 12 months; among those in the control group, 743 (2.2%) had a cervical cytology collected. The rate of CIN2+ detection was 3.9 cases per 1,000 eligible women in the intervention group (95% CI 2.9,5.3, p<0.001) compared to 0.3 cases per 1,000 eligible women in the control group (95% CI 0.2,0.6). The study also demonstrated that women who have been insufficiently screened at age 50-64 had higher HPV prevalence and tended to have more CIN2+ lesions diagnosed compared to sufficiently screened women, and that insufficiently screened women were more likely to request vaginal self-sampling— supporting the idea that this screening modality might be ideal for this population.

Tranberg adds, “A catch-up HPV screening test could potentially improve cervical cancer prevention in women aged 65 years and older who have never had an HPV test. Older insufficiently screened women were more likely to self-collect a vaginal sample for HPV testing in their own home as compared to sufficiently screened women; hence this screening modality could be ideal to identify older women at risk of cervical cancer.”

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004253

Citation: Tranberg M, Petersen LK, Hammer A, Elfström M, Blaakær J, Jørgensen SF, et al. (2023) Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study. PLoS Med 20(7): e1004253. https://doi.org/10.1371/journal.pmed.1004253

Author Countries: Denmark, Sweden

Funding: The study was partly funded by the Health Foundation (grant no.:18-B-0125 to MT). Funder website: https://helsefonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS Medicine

DOI

10.1371/journal.pmed.1004253

Method of Research

Observational study

Subject of Research

People

COI Statement

Competing Interests: see manuscript

Share12Tweet8Share2ShareShareShare2

Related Posts

Wearable monitor improves diagnosis of heart rhythm disorders after fainting

August 31, 2026

Visualisation of magnetic field-induced nanoparticle clusters and mechanical property changes in a breast phantom for inductive moderate hyperthermia

August 31, 2026

Multidisciplinary intervention in frail elderly patients with cardiovascular diseases: a multicentre, single-blinded, randomised controlled trial

August 31, 2026

Machine Learning Model Development and Evaluation for Non-contact Lower Limb Injury Risk Prediction in Elite Male Rugby Union: A Multi-team, Multi-season Analysis

August 31, 2026

POPULAR NEWS

  • β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

    29 shares
    Share 12 Tweet 7
  • Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

    29 shares
    Share 12 Tweet 7
  • KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

    29 shares
    Share 12 Tweet 7
  • Virologist awarded $2 million NIH grant to investigate how virus-infected cells live and die

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.